AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol

INTRODUCTION: Sepsis is a leading global cause of morbidity and mortality, and is more common at the extremes of age. Moreover, the cost of in-hospital care for elderly patients with sepsis is significant. There are indications from experimental and observational studies that aspirin may reduce infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisen, Damon P, Moore, Elizabeth M, Leder, Karin, Lockery, Jessica, McBryde, Emma S, McNeil, John J, Pilcher, David, Wolfe, Rory, Woods, Robyn L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253551/
https://www.ncbi.nlm.nih.gov/pubmed/28110287
http://dx.doi.org/10.1136/bmjopen-2016-013636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253551/
https://www.ncbi.nlm.nih.gov/pubmed/28110287
http://dx.doi.org/10.1136/bmjopen-2016-013636

Ejemplares similares